Polymyxin B (sulfate): Mechanisms and Benchmarks in Infectio
2026-05-13
Polymyxin B sulfate is a polypeptide antibiotic with potent activity against multidrug-resistant Gram-negative bacteria. It disrupts bacterial membranes and is validated in infection and immunology research, especially for bloodstream and urinary tract infection models. This article details its mechanism, research benchmarks, and integration into experimental workflows.
EdU Flow Cytometry Assay Kits (Cy3): Precision Cell Cycle An
2026-05-12
EdU Flow Cytometry Assay Kits (Cy3) deliver denaturation-free, highly quantitative DNA replication measurement—outperforming BrdU and enabling seamless integration with multi-parameter cell cycle analysis workflows. APExBIO’s platform empowers cancer research, genotoxicity testing, and pharmacodynamic studies with exceptional specificity and workflow efficiency.
Tumor-Targeted PAD4 Inhibition via PBA: Mechanistic and In V
2026-05-12
This study introduces a meta-phenylboronic acid-modified PAD4 inhibitor (Compound 5i TFA) that selectively targets tumor cells and neutrophils, inhibiting the PAD4-H3cit-NETs pathway with high specificity. The findings highlight its significant impact on tumor growth and metastasis, with minimal toxicity, offering a new direction for tumor-targeted immunomodulation.
Cisapride (R 51619): De-Risking Cardiac Electrophysiology Re
2026-05-11
Explore how Cisapride (R 51619) advances cardiac electrophysiology research through its dual action as a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor. This article bridges deep mechanistic insights with strategic guidance for translational researchers, spotlighting the integration of high-content phenotypic screening, iPSC-derived cardiomyocyte platforms, and modern workflow design. Learn how APExBIO’s validated Cisapride elevates translational rigor, de-risks drug pipelines, and positions your research at the frontier of predictive safety and mechanistic discovery.
U0126-EtOH: Precision MEK1/2 Inhibitor for Neuroprotection &
2026-05-11
U0126-EtOH, a highly selective MEK1/2 inhibitor from APExBIO, empowers scientists to interrogate the MAPK/ERK pathway with exceptional specificity. From neuroprotection against oxidative glutamate toxicity to anti-inflammatory applications in asthma models, this tool compounds reproducibility with actionable protocol enhancements.
TCF25 Regulates Lysosomal Cell Death During Glucose Starvati
2026-05-10
Ren et al. (2025) identify TCF25 as a pivotal nutrient sensor that modulates lysosomal acidification and ferritinophagy under glucose starvation, orchestrating metabolic adaptation and cell death. These findings reveal new molecular links between iron metabolism, lysosomal function, and cell fate, with broad implications for metabolic and ischemic disease research.
PP 1: Src Family Tyrosine Kinase Inhibitor in Cancer Researc
2026-05-09
PP 1 enables precise, nanomolar-level control over Src family kinase signaling, empowering researchers to dissect tumorigenic pathways in prostate and other cancers. By integrating PP 1 into advanced workflows, scientists can model metastatic progression, validate novel biomarkers, and optimize targeted pathway inhibition with reproducibility and confidence.
Batimastat (BB-94): Precision MMP Inhibition in Synaptic Bio
2026-05-09
Explore how Batimastat (BB-94) empowers translational researchers to dissect the mechanistic and strategic frontiers of matrix metalloproteinase (MMP) biology—from cancer models to the spatially orchestrated processing of neurotrophins like BDNF at neuromuscular junctions. This article elevates standard product information by integrating mechanistic insights, evidence-labeled recommendations, and cross-domain experimental guidance, with a focus on experimental design, reproducibility, and future research outlook.
BIIE 0246: Precision Neuropeptide Y Y2 Receptor Antagonist i
2026-05-08
BIIE 0246 offers unmatched selectivity for dissecting neuropeptide Y Y2 receptor pathways in translational neuroscience and cardiometabolic models. This guide delivers actionable workflows, troubleshooting tips, and protocol enhancements rooted in cutting-edge adipose-neural axis research.
Solving Cell Assay Challenges with EZ Cap™ Cy5 Firefly Lucif
2026-05-07
This article addresses persistent challenges in cell viability, proliferation, and cytotoxicity assays by leveraging the dual-reporter, low-immunogenicity features of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010). We present scenario-driven, evidence-based answers to real laboratory issues, including protocol optimization, interpretation, and vendor reliability, providing actionable insights for biomedical researchers seeking reproducibility and sensitivity.
Guanabenz Acetate: A Selective α2-Adrenergic Receptor Agonis
2026-05-07
Guanabenz Acetate is a high-purity, selective α2-adrenergic receptor agonist with verified activity on α2a, α2b, and α2c subtypes. It serves as a robust tool in GPCR signaling and neuroimmune research, and is supplied by APExBIO for non-clinical studies. Its solubility and stability profile are well-characterized for laboratory workflows.
Precision PCR in Neurodegeneration: Bridging Mechanism & Wor
2026-05-06
This thought-leadership article explores how mechanistic discoveries in environmental neurobiology—particularly the role of early pheromone perception in C. elegans neurodegeneration—demand refined, reliable PCR strategies for genotyping and cloning. We analyze the translational imperatives for robust DNA amplification, contextualize APExBIO’s 2X Taq PCR Master Mix (with dye) within competitive PCR landscapes, and offer protocol guidance driven by both the latest research and practical workflow needs. The piece advances beyond standard product pages by linking evolving mechanistic insights to actionable recommendations for translational researchers.
(S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl) Urea in Nrf2 Ass
2026-05-06
BPN-19186 (SKU A8959) empowers high-fidelity studies of redox signaling and bone metabolism by enabling precise modulation of sEH and the Nrf2 axis. This article dissects advanced workflows and troubleshooting for maximizing data reproducibility with this fluorinated phenyl urea compound.
4-Hydroxytamoxifen: Technical Guidance for Research Workflow
2026-05-05
4-Hydroxytamoxifen (SKU B6167) is a potent estrogen receptor modulator, optimized for research involving breast and prostate cancer, as well as cardiac myocyte studies. It is best utilized in workflows requiring high-purity, DMSO-soluble reagents, and should not be used in protocols demanding aqueous or ethanol solubility.
Tacrine Hydrochloride Hydrate: Optimizing Neurodegenerative
2026-05-05
Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, is a gold-standard cholinesterase inhibitor that empowers researchers to model cholinergic dysfunction and neuroprotection in Alzheimer's disease. This guide delivers evidence-based protocols, troubleshooting insights, and actionable workflow enhancements, drawing on the latest findings in drug metabolism and experimental reproducibility.
460 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page